Skip to main content

Published locations for FDA Panel Backs Sunitinib for Pancreatic Neuroendocrine Tumors

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA Panel Backs Sunitinib for Pancreatic Neuroendocrine Tumors

User login

  • Reset your password
  • /content/fda-panel-backs-sunitinib-pancreatic-neuroendocrine-tumors
  • /internalmedicinenews/article/33772/oncology/fda-panel-backs-sunitinib-pancreatic-neuroendocrine
  • /oncologypractice/article/33772/oncology/fda-panel-backs-sunitinib-pancreatic-neuroendocrine-tumors
  • /hematology-oncology/article/33772/oncology/fda-panel-backs-sunitinib-pancreatic-neuroendocrine
  • /internalmedicine/article/33772/oncology/fda-panel-backs-sunitinib-pancreatic-neuroendocrine-tumors